These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1485282)

  • 1. [Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex].
    von Felten A
    Ther Umsch; 1992 Dec; 49(12):837-42. PubMed ID: 1485282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].
    Schoch U; Zanetti E; von Felten A
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1807-10. PubMed ID: 2962279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
    Hofmann M; Casper F; Prellwitz W; Brockerhoff P
    Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer and thrombin-antithrombin III complexes in patients with clinically suspected pulmonary embolism.
    Demers C; Ginsberg JS; Johnston M; Brill-Edwards P; Panju A
    Thromb Haemost; 1992 Apr; 67(4):408-12. PubMed ID: 1631787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the role of low-molecular-weight heparins in pregnancy.
    Greer IA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group.
    Thromb Haemost; 1993 Dec; 70(6):909-14. PubMed ID: 8165610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of thrombosis in pregnancy].
    Winkler UH; Schindler AE
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):301-12. PubMed ID: 8766488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improved postoperative prevention of thrombosis in trauma surgery by dose adjusted low molecular weight heparin based on TAT and D-dimer values].
    Hansen M; Mayer A; Peetz D; Hafner G; Prellwitz W; Rommens PM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1213-7. PubMed ID: 9931839
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of pregnancy in women with antithrombin III congenital defect: report of four cases.
    De Stefano V; Leone G; De Carolis S; Ferrelli R; Di Donfrancesco A; Moneta E; Bizzi B
    Thromb Haemost; 1988 Apr; 59(2):193-6. PubMed ID: 3164529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Deep venous thrombosis in pregnancy: risk factors and possibilities for prevention].
    Heilmann L; Hojnacki B; Fischer WM
    Z Geburtshilfe Perinatol; 1990; 194(6):275-8. PubMed ID: 2080648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of thromboembolism with a low-dose heparin regimen in acute stroke].
    Mück AO; Heinrich F
    Med Klin (Munich); 1992 Aug; 87(8):422-7. PubMed ID: 1406475
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy.
    Zotz RB; Gerhardt A; Scharf RE
    Semin Thromb Hemost; 2003 Apr; 29(2):143-54. PubMed ID: 12709917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of thromboembolism with low molecular weight heparin (Dalteparin-Na) in risk pregnancy].
    Schinzel H; Bahlmann F; Peetz D; Savvidis S; Himmrich L; Klotz M
    Med Klin (Munich); 2002 Apr; 97(4):193-203. PubMed ID: 11977574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
    Bombeli T; Raddatz Mueller P; Fehr J
    Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of drug prevention of thromboembolism in urologic risk patients].
    Schulz B; Winter P; Heinrichs C
    Z Urol Nephrol; 1987 Jan; 80(1):37-42. PubMed ID: 2437732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The optimization of the heparin prophylaxis of postoperative thromboembolic complications].
    Nozdrachev IuI
    Vestn Khir Im I I Grek; 1995; 154(2):61-5. PubMed ID: 8540191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.